These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 34958299

  • 1. The effect of sodium zirconium cyclosilicate on acid-base balance in chronic kidney disease.
    Mori D, Namiki Y, Sugimachi A, Kado M, Tamai S, Nomi H, Haga R, Nagatoya K, Yamauchi A.
    Clin Nephrol; 2022 May; 97(5):255-260. PubMed ID: 34958299
    [Abstract] [Full Text] [Related]

  • 2. Sodium zirconium cyclosilicate and metabolic acidosis: Potential mechanisms and clinical consequences.
    Fernandez-Prado R, Villalvazo P, Avello A, Gonzalez-de-Rivera M, Aguirre M, Carrasco-Muñoz CG, Fernandez-Fernandez B, Martin-Cleary C, Carriazo S, Sanchez-Niño MD, Perez-Gomez MV, Ortiz A.
    Biomed Pharmacother; 2023 Feb; 158():114197. PubMed ID: 36916426
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P, Shah S, McAlister L, Cleghorn S, King L, Shroff R.
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [Abstract] [Full Text] [Related]

  • 4. Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.
    Ash SR, Batlle D, Kendrick J, Oluwatosin Y, Pottorf W, Brahmbhatt Y, Guerrieri E, Fried L.
    Nephron; 2022 Apr; 146(6):599-609. PubMed ID: 35462371
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fecal ammonium in mice with CKD: gastrointestinal sequestration by sodium zirconium cyclosilicate.
    Marmol F, Badaruddin M, Baig A, Ye M, Wysocki J, Tahaei E, Welling P, Bamberg K, Batlle D.
    Am J Physiol Renal Physiol; 2023 May 01; 324(5):F464-F471. PubMed ID: 37022945
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis.
    Fu X, Zhang S, Gao F, Mao N.
    Clin Nephrol; 2024 Oct 01; 102(4):223-231. PubMed ID: 38994592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
    Roger SD, Lavin PT, Lerma EV, McCullough PA, Butler J, Spinowitz BS, von Haehling S, Kosiborod M, Zhao J, Fishbane S, Packham DK.
    Nephrol Dial Transplant; 2021 Jan 01; 36(1):137-150. PubMed ID: 32030422
    [Abstract] [Full Text] [Related]

  • 14. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C, Nassar T, Qunibi W.
    Expert Opin Pharmacother; 2021 Jan 01; 22(1):19-28. PubMed ID: 32892634
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness analysis of sodium zirconium cyclosilicate for treating hyperkalemia among Chinese patients.
    Tian L, Fu S, Li M, Zhao X, Li H.
    Front Public Health; 2023 Jan 01; 11():1196789. PubMed ID: 38145082
    [Abstract] [Full Text] [Related]

  • 16. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF.
    Am J Health Syst Pharm; 2023 Sep 07; 80(18):1238-1246. PubMed ID: 37335862
    [Abstract] [Full Text] [Related]

  • 17. An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China.
    Lu Y, Liu BC, Liu H.
    Expert Opin Pharmacother; 2023 Feb 07; 24(3):301-308. PubMed ID: 36617700
    [Abstract] [Full Text] [Related]

  • 18. Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Oshima A, Imamura T, Narang N, Kinugawa K.
    Clin Cardiol; 2021 Sep 07; 44(9):1272-1275. PubMed ID: 34263946
    [Abstract] [Full Text] [Related]

  • 19. Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia.
    Hoy SM.
    Drugs; 2018 Oct 07; 78(15):1605-1613. PubMed ID: 30306338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.